Delivery Order SPE2DB22D2007-SPE2DB25FJ4PW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a contract ceiling value of $1,203.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valtoco 15 mg nasal spray with a ceiling value of $1,128.54. This is a firm fixed price, non-set-aside delivery order that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays under a firm fixed-price contract with a ceiling value of $1,543.14. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for Valtoco 10 mg nasal sprays, with a ceiling value of $1,140.52 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of June 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $2,114.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Valtoco 15 mg nasal sprays. The contract employs firm fixed-price pricing and is scheduled for completion by August 15, 2025. This non-competitive delivery order will be fulfilled from the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays valued at $1,355.52 on May 20, 2025, with an ultimate completion date of May 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $2,551.20 and ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $2,613.58 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with a completion deadline of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,302.65 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray on September 16, 2025, with completion expected by September 17, 2025. This non-set-aside, firm fixed price contract represents a small-value order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, valued at $2,839.00, with an ultimate completion date of September 10, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4PWDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This firm fixed-price delivery order represents a non-set-aside competitive award performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract is scheduled for completion by September 4, 2025, indicating a rapid fulfillment timeline typical of urgent medical supply needs within the federal healthcare system. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal military and veteran healthcare systems, AmerisourceBergen maintains a comprehensive contract portfolio with DLA covering a wide range of medications and medical supplies. The Valtoco delivery represents the company's continued role as a critical vendor for specialized pharmaceutical products supporting Defense Health Agency requirements and broader government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/3/25 |